Literature DB >> 3166910

A regression analysis of prognostic factors after resection of Dukes' B and C carcinoma of the rectum and rectosigmoid. Does post-operative radiotherapy change the prognosis?

S M Bentzen1, I Balslev, M Pedersen, P S Teglbjaerg, F Hanberg-Soerensen, J Bone, N O Jacobsen, J Overgaard, A Sell, K Bertelsen.   

Abstract

The prognostic value of several clinical and histopathological characteristics has been evaluated in patients with Dukes' B and C carcinoma of the rectum and the rectosigmoid. Data on 260 Dukes' B and 208 Dukes' C tumours entered into a prospective, randomized clinical trial of post-operative radiotherapy (50 Gy given with 2 Gy/fraction in an overall time of 7 weeks) were analyzed by means of the Cox proportional hazards model. The Dukes' stages B and C were analyzed in two separate multivariate analyses. In patients with Dukes' B tumours, a poor prognosis was associated with age above 60, perineural and venous invasion, tumour located less than 10 cm from the anal verge and elevated pre-operative carcinoembryonic antigen (CEA) (greater than 3.2 ng ml-1). In patients with Dukes' C tumours, perineural and venous invasion, tumour located less than 10 cm from the anal verge, and elevated pre-operative CEA were associated with a poor prognosis. In addition, a large tumour diameter had a strong, negative influence on the prognosis. Males seemed to have a poorer prognosis than females among the Dukes' C patients. Resection of neighbouring organs was also associated with a poor prognosis in this stage. Post-operative radiotherapy as administered in the present series had no significant influence on prognosis. Based on the derived prognostic models patients with a hazard of death above the median in each stage were selected. A separate analysis of the survival in these high risk patients showed no survival benefit from radiotherapy. The proportional hazards model may be a useful tool in selecting patients for more aggressive adjuvant treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3166910      PMCID: PMC2246758          DOI: 10.1038/bjc.1988.192

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  THE SPREAD OF CARCINOMA OF THE RECTUM: INVASION OF LYMPHATICS, VEINS AND NERVES.

Authors:  P H Seefeld; J A Bargen
Journal:  Ann Surg       Date:  1943-07       Impact factor: 12.969

2.  Survival after operations for rectal carcinoma in patients over 70 years of age.

Authors:  G E Block; W E Enker
Journal:  Ann Surg       Date:  1971-09       Impact factor: 12.969

3.  The prognostic value of the modifications of the Dukes' C class of colorectal cancer. An analysis of the NSABP clinical trials.

Authors:  N Wolmark; B Fisher; H S Wieand
Journal:  Ann Surg       Date:  1986-02       Impact factor: 12.969

4.  Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer.

Authors:  H J Wanebo; B Rao; C M Pinsky; R G Hoffman; M Stearns; M K Schwartz; H F Oettgen
Journal:  N Engl J Med       Date:  1978-08-31       Impact factor: 91.245

5.  Correlation of histopathologic characteristics of primary tumor and uninvolved regional lymph nodes in Dukes' class C colonic carcinoma with prognosis.

Authors:  G S Thynne; L H Weiland; C G Moertel; A Silvers
Journal:  Mayo Clin Proc       Date:  1980-04       Impact factor: 7.616

6.  Rectal cancer: adjuvant radiation therapy.

Authors:  J P Green
Journal:  Front Radiat Ther Oncol       Date:  1980

7.  The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases.

Authors:  J R Jass; W S Atkin; J Cuzick; H J Bussey; B C Morson; J M Northover; I P Todd
Journal:  Histopathology       Date:  1986-05       Impact factor: 5.087

8.  The relationship of survival to staging and grading of colorectal carcinoma: a prospective study of 503 cases.

Authors:  R C Newland; P H Chapuis; M T Pheils; J G MacPherson
Journal:  Cancer       Date:  1981-03-15       Impact factor: 6.860

9.  Adjuvant postoperative radiotherapy in carcinoma of the rectum and rectosigmoid.

Authors:  R B Hoskins; L L Gunderson; D E Dosoretz; T A Rich; J Galdabini; G Donaldson; A M Cohen
Journal:  Cancer       Date:  1985-01-01       Impact factor: 6.860

10.  Postoperative radiotherapy in rectosigmoid cancer Dukes' B and C: interim report from a randomized multicentre study.

Authors:  I Balslev; M Pedersen; P S Teglbjaerg; F Hanberg-Sørensen; J Bone; N O Jacobsen; J Overgaard; A Sell; K Bertelsen; E Hage; L Hansen; O Kronborg; H Høstrup; B Nørgaard-Pedersen
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

View more
  3 in total

Review 1.  Surgical excision alone is adequate treatment for primary colorectal cancer.

Authors:  R Hind; D R Rew; C D Johnson
Journal:  Ann R Coll Surg Engl       Date:  1992-01       Impact factor: 1.891

2.  Stromal tenascin distribution as a prognostic marker in colorectal cancer.

Authors:  U Kressner; G Lindmark; B Tomasini-Johansson; R Bergström; B Gerdin; L Påhlman; B Glimelius
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis.

Authors:  S M Bentzen; I Balslev; M Pedersen; P S Teglbjaerg; F Hanberg-Sørensen; J Bone; N O Jacobsen; A Sell; J Overgaard; K Bertelsen
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.